Latest News about ROIV
Recent news which mentions ROIV
2 Nasdaq Stocks That Could Soar This Week
July 16, 2023
From Motley Fool
From Benzinga
From Benzinga
Acadia stock rallies on drug news as Roivant also climbs, while Leslie’s, Theseus shares plunge and more moving stocks
July 14, 2023
From MarketWatch
From Benzinga
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
June 28, 2023
From MarketWatch
From Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
From Benzinga
Why Roivant Sciences Stock Is Perking Up Today
June 22, 2023
From Motley Fool
From Benzinga
From Benzinga
Marching Towards FDA Approval: Dermavant's Vtama Cream Excels in Phase 3 Trial, Eyes 2024 Submission
May 16, 2023
Tickers
ROIV
From Benzinga
Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?
April 23, 2023
From Motley Fool
From Motley Fool
EXCLUSIVE: Joe Biden Tops 2024 Election Betting Odds, How Negative Headlines And Indictment Move Trump Ahead Of DeSantis
April 17, 2023
From Benzinga
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
April 17, 2023
From Motley Fool
Prometheus Biosciences, XPeng And Other Big Stocks Moving Higher In Monday's Pre-Market Session
April 17, 2023
From Benzinga
From InvestorPlace
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 21, 2023
From Benzinga
Roivant Sciences Highlights Topline Data From Atopic Dermatitis Drug In Patients As Young As 2 Years
March 15, 2023
Tickers
ROIV
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.